The National Academy of Medicine (NAM) recently announced the launch of the NAM Scholars in Diagnostic Excellence program with funding from the Gordon and Betty Moore Foundation. This new program, in partnership with CMSS, will support up to 10 scholars in a one-year, part-time remote experience to enhance the scholars’ knowledge and skills in diagnostic quality and safety, and accelerate their career development toward becoming national leaders in the field.  Scholars will build upon the work of the National Academies of Sciences, Engineering, and Medicine consensus report Improving Diagnosis in Health Care (2015) and propose the implementation of projects that will improve diagnosis and reduce diagnostic errors at the national level.

“We are very pleased to partner with the National Academy of Medicine on the new Scholars in Diagnostic Excellence program,” said Helen Burstin, CMSS chief executive officer. “Given the depth and breadth of CMSS’s membership, this new scholars program presents an important opportunity to offer strategies to address diagnostic excellence across the full house of medicine.”

The call for applications will open in January 2021, with the first cohort of scholars to begin their program participation in July 2021. An NAM-appointed advisory committee will select scholars who are interested in focusing on diagnosis-related work from a broad range of disciplines and professions — including physicians, advanced practice clinicians, quality experts, informaticians, and researchers.

Read the full Press Release (October 15, 2020)

For more information and to express interest, visit the Program Website: nam.edu/diagnosticscholars